SCHEMBL25355644

SCHEMBL25355644

Fc1cc(-c2nnc(C(F)F)o2)ccc1Cn1cc(-c2ccc(CN3CC(F)C3)cc2)nn1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 5/20 0.51
▸ HDAC1 Q13547 13/20 0.41
▸ PTGS2 P35354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25350933 0.94 HDAC6 (0.49) HDAC6HDAC1
SCHEMBL25350928 0.94 HDAC6 (0.49) HDAC6HDAC1
SCHEMBL25351888 0.94 HDAC6 (0.49) HDAC6HDAC1
SCHEMBL25993068 0.91 HDAC6 (0.43) HDAC6HDAC1
SCHEMBL30407979 0.89 HDAC6 (0.50) HDAC6HDAC1
SCHEMBL24216737 0.89 HDAC6 (0.50) HDAC6HDAC1
SCHEMBL25350761 0.89 HDAC6 (0.50) HDAC6HDAC1
SCHEMBL25350175 0.89 HDAC6 (0.61) HDAC6HDAC1PTGS2
SCHEMBL25351995 0.88 HDAC6 (0.49) HDAC6HDAC1
SCHEMBL25349300 0.88 HDAC6 (0.49) HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885HDAC1 2/4885PTGS2 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback